Christian T Farrar Selected Research

Christian T Farrar Research Topics

Disease

14	Neoplasms (Cancer) 01/2022 - 05/2009
6	Fibrosis (Cirrhosis) 01/2020 - 09/2015
5	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 05/2009
4	Liver Cirrhosis (Hepatic Cirrhosis) 07/2018 - 09/2015
2	Necrosis 04/2016 - 11/2012
2	Alzheimer Disease (Alzheimer's Disease) 01/2014 - 11/2011
2	Amyloid Plaque 01/2014 - 11/2011
2	Stroke (Strokes) 06/2013 - 04/2013
2	Brain Neoplasms (Brain Tumor) 11/2012 - 05/2009
2	Breast Neoplasms (Breast Cancer) 11/2012 - 10/2012
2	Glioma (Gliomas) 03/2011 - 07/2010
2	Edema (Dropsy) 03/2011 - 05/2009
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2020
1	Neoplasm Metastasis (Metastasis) 01/2017
1	Nephrogenic Fibrosing Dermopathy 01/2017
1	Cardiotoxicity 01/2017
1	Herpes Simplex 06/2015
1	Hypercapnia 04/2013
1	Medulloblastoma 02/2013
1	Brain Edema (Cerebral Edema) 07/2010
1	Myocardial Infarction 06/2008
1	Ischemia 12/2007
1	Lactic Acidosis 12/2007
1	Brain Ischemia (Cerebral Ischemia) 09/2007
1	Insulin Resistance 06/2007

Drug/Important Bio-Agent (IBA)

5	CollagenIBA 01/2020 - 05/2009
5	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 04/2016 - 05/2009
5	Biomarkers (Surrogate Marker)IBA 09/2013 - 05/2009
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 06/2015
4	Collagen Type I (Type I Collagen)IBA 01/2020 - 09/2015
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2016 - 05/2009
3	Contrast MediaIBA 01/2020 - 11/2011
3	GadoliniumIBA 01/2018 - 11/2011
3	cediranib (AZD2171)IBA 04/2016 - 05/2009
2	Protons (Proton)IBA 10/2021 - 12/2007
2	AmidesIBA 10/2021 - 12/2007
2	Lysine (L-Lysine)FDA Link 11/2020 - 06/2015
2	streptococcal polysaccharide type III group BIBA 01/2020 - 01/2018
2	Hydroxyproline (4 Hydroxyproline)IBA 07/2018 - 09/2015
2	Messenger RNA (mRNA)IBA 07/2018 - 09/2007
2	Pharmaceutical PreparationsIBA 01/2017 - 11/2012
2	Gadolinium DTPA (Magnevist)FDA Link 06/2013 - 10/2012
1	folfirinoxIBA 01/2020
1	allysineIBA 01/2020
1	gadolinium 1,4,7,10- tetraazacyclododecane- N,N',N'',N'''- tetraacetateIBA 01/2020
1	EDP-305IBA 07/2018
1	MineralsIBA 01/2017
1	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 01/2017
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2017
1	Liposomes (Liposome)IBA 01/2017
1	MEDI3617IBA 04/2016
1	Sirolimus (Rapamycin)FDA Link 09/2015
1	Nucleotide AptamersIBA 01/2014
1	Biological ProductsIBA 09/2013
1	SolutionsIBA 04/2013
1	Neuropilin-1IBA 02/2013
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 02/2013
1	Epidermal Growth Factor (EGF)IBA 11/2012
1	Trastuzumab (Herceptin)FDA Link 11/2012
1	Lapatinib (GW572016)FDA Link 11/2012
1	EP-2104RIBA 10/2012
1	FibrinIBA 10/2012
1	Peptides (Polypeptides)IBA 10/2012
1	Coloring Agents (Dyes)IBA 11/2011
1	Indicators and Reagents (Reagents)IBA 11/2011
1	Tumor Biomarkers (Tumor Markers)IBA 03/2011
1	Angiopoietin-2IBA 07/2010
1	Phosphotransferases (Kinase)IBA 05/2009
1	Endothelial Growth FactorsIBA 05/2009
1	monocrystalline iron oxide nanoparticle (MION)IBA 06/2008
1	APTIBA 12/2007
1	Actins (F Actin)IBA 09/2007
1	Stavudine (Zerit)FDA LinkGeneric 06/2007
1	Mitochondrial DNA (mtDNA)IBA 06/2007
1	Glucose (Dextrose)FDA LinkGeneric 06/2007

Therapy/Procedure

11	Therapeutics 01/2022 - 04/2010
2	Oncolytic Virotherapy 01/2022 - 11/2020
1	Neoadjuvant Therapy 01/2020
1	Drug Therapy (Chemotherapy) 01/2017
1	Ligation 09/2015